Case report

Effective treatment of pulmonary adenocarcinoma harboring triple EGFR mutations of L858R, T790M, and cis-C797S by osimertinib, bevacizumab, and brigatinib combination therapy: a case report

Zhao J, Zou M, Lv J, Han Y, Wang G, Wang G

OncoTargets and Therapy 2018, 11:5545-5550

Published Date: 6 September 2018